囊性赤道球菌病的医疗管理
1Faculty of Infectious and Tropical Diseases, The London School of Hygiene and Tropical Medicine, London, UK.
Current opinion in infectious diseases
|August 18, 2023
概括
囊性赤道球菌病的治疗是不理想的,药物选择有限. 研究正在探索改进的药物配方,药物的重新用途和天然产品,以对抗这种被忽视的动物传染病.
科学领域:
- 寄生虫学的寄生虫学
- 传染性疾病 传染性疾病
- 药物发现 药物发现 药物发现
背景情况:
- 囊性球菌是一种被忽视的动物传染病,分布在全球,影响低收入和高收入国家.
- 目前用于囊性赤道球菌病的医疗管理,主要是胺醇与潜在的praziquantel添加,不是最佳的,并且在近四十年来几乎没有看到很大的进步.
研究的目的:
- 审查最近的发现,并强调急需改善囊性球菌病治疗策略的迫切需要.
- 探索新的药物配方方法,药物重用和天然产品研究,以治疗这种被忽视的寄生虫感染.
主要方法:
- 关于囊性球菌病管理的当前文献的综述.
- 对梅本达和阿尔本达配方和药物输送的研究进行调查.
- 探索药物重用和天然产品查新抗赤道球菌病剂.
主要成果:
- 对梅本达治疗癌症的研究引发了对新配方的兴趣,以增强其用于囊性赤道球菌病的生物利用性.
- 有证据支持将阿尔本达与脂肪食物一起服用,以提高疗效.
- 制药公司正在扩大药物捐赠计划,研究重点是重新利用现有的药物和天然产品.
结论:
- 囊性赤道球菌病的医疗治疗仍然被忽视,需要更好地了解现有的药物.
- 药物再利用为开发新的有效治疗方法提供了一个有前途的途径.
- 对新型药物配方和天然产品的持续研究对于推进囊性赤道真菌病治疗至关重要.
相关概念视频
Cystic Fibrosis: Management
194
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
194
Chronic Pancreatitis II: Collaborative Care
113
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
113
Nephrotic Syndrome II : Assessment and Medical Management
8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
Nephrotic Syndrome III : Nursing Management
19
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
19
Cardiomyopathy V: Interprofessional Care
16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K


